A biopharmaceutical company, which focuses on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin-based therapeutics.


Updates from The Motley Fool

Latest updates on Palatin Technologies from Fool.com.


Stock Performance

PTN vs. S&P 500 | 2 Year Performance
View Interactive PTN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Palatin Technologies.
Current Price: $0.65
Prev Close: $0.60
Open: $0.61
Bid: $0.62
Ask: $0.65
Day's Range: $0.58 - $0.68
52wk Range: $0.36 - $0.90
Volume: 4,196,587
Avg Vol 1,384,753
Market Cap: $44.36M
P/E (ttm): -1.82
EPS (ttm): -$0.33
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Palatin Technologies.
CAPS Rating 4 out of 5
 
117 Outperform
5 Underperform
CAPS All Stars
 
22 Outperform
2 Underperform

How do you think Palatin Technologies will perform against the market?



You pick for Palatin Technologies is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Carl Spana, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Palatin Technologies.

A biopharmaceutical company, which focuses on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin-based therapeutics.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers